Use of Povetacicept in Treatment of IgA Nephropathy
Drs Jonathan Barratt and Brad Rovin comment on clinical trial data regarding the use of povetacicept for the treatment of IgAN.
Source: hcplive.com
Complement Inhibition News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Complement Inhibition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Complement Inhibition Today - Breaking & Trending Today
Dual Inhibition of BlyS and APRIL in IgA Nephropathy
Nephrology experts explore the role of dual inhibition of BlyS and APRIL in the treatment of IgAN, and how this can impact disease pathogenesis.
Source: hcplive.com
New Therapies in IgA Nephropathy
Brad Rovin, MD, outlines the use of complement inhibitors as an alternative to systemic glucocorticoids for the treatment of IgAN.
Source: hcplive.com
The Pathophysiology of IgAN and Use of Immunomodulating Therapies
An expert nephrologist provides an overview of the pathophysiology of IgAN before discussing new immunomodulating therapies in clinical trials.
Source: hcplive.com
Complement therapy in transplant patients in C3G
Anuja Java, MD, discusses the role of complement inhibitors in transplant patients with C3G.
Source: hcplive.com